Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
20,640 total articles
Nkarta, Inc., a clinical-stage biopharmaceutical company specializing in engineered natural killer (NK) cell therapies for autoimmune diseases, announced its participation in the 25th Annual Needham Virtual Healthcare Conference. Company executives will discuss their investigational CAR-NK cell therapy targeting B cell-mediated autoimmune diseases …
Seres Therapeutics announced its presentation at the 2026 CARB-X Investor Day, underscoring its ongoing collaboration with CARB-X to develop novel live biotherapeutics targeting antimicrobial resistance (AMR). The company highlighted its advancement of SER-428, an oral liquid formulation intended for ICU patients at high risk of AMR infections, sup…
Kymera Therapeutics announced that Gilead Sciences has exercised its option to exclusively license KT-200, a novel oral CDK2 molecular glue degrader developed by Kymera. This triggers a $45 million milestone payment to Kymera, with Gilead advancing the program toward IND-enabling studies for a potential 2027 IND filing. KT-200 offers a targeted the…
Satellos Bioscience Inc., a clinical-stage biotechnology company focused on therapies for degenerative muscle diseases, announced its participation in the Bloom Burton & Co. Healthcare Investor Conference in April 2026. CEO Frank Gleeson will present on the company's progress with its oral small molecule drug SAT-3247 targeting muscle repair in Duc…
Rani Therapeutics, a clinical-stage biotherapeutics company listed on Nasdaq, announced the appointment of Dr. Sara Kenkare-Mitra as Strategic Advisor. Dr. Kenkare-Mitra brings extensive expertise in biologics development and will support the advancement of Rani's oral biologics platform, including their RaniPill technology and programs such as ora…
The Scotts Miracle-Gro Company has finalized the divestiture of its subsidiary, The Hawthorne Gardening Company, to cannabis operator Vireo Growth. The transaction supports ScottsMiracle-Gro's strategy to concentrate on its core lawn and garden products, with no impact on its full fiscal 2026 guidance. The company expects the divestiture to aid mar…
Shoals Technologies Group, a leading manufacturer of electrical infrastructure solutions for solar, battery storage, and data centers, announced it will release its first quarter 2026 earnings on May 5, 2026, before market open, followed by a conference call. The company also highlighted its role in advancing energy transition technologies.
Foghorn Therapeutics announced upcoming presentations of new preclinical data for its selective SMARCA2 inhibitor FHD-909 and other degrader programs targeting CBP, EP300, and ARID1B at the 2026 AACR Annual Meeting. The data suggest potential expansion opportunities for combination therapies in various cancer types, reinforcing the company's innova…
Biodesix has been recognized as a 2026 USA TODAY Top Workplaces award winner for the third consecutive year, a designation based on direct employee feedback regarding workplace experience and culture. The award reflects Biodesix's commitment to a people-first culture that fosters trust, collaboration, and accountability, supporting its mission to i…
ConnectOne Bancorp, Inc. announced it will release its first quarter 2026 financial results prior to market open on April 23, 2026, followed by a conference call led by its CEO and CFO. The call will discuss the company's financial performance and operating results, and it will be accessible to investors via webcast and replay.
The Simply Good Foods Company reported a net loss of $159.7 million for Q2 fiscal 2026, a significant decline from net income in the prior year period. Net sales declined by 9.4%, driven by poor performances in Atkins and OWYN brands, partially offset by slight Quest growth. The company took a $249 million non-cash impairment charge on Atkins and O…
Indivior Pharmaceuticals will release its first quarter 2026 financial results on April 30, 2026, followed by a live webcast presentation by CEO Joe Ciaffoni and other executives. The company is a leader in long-acting injectable treatments for opioid use disorder and emphasizes its commitment to advancing treatments and understanding of OUD.
SUNation Energy, a Nasdaq-listed solar energy provider, announced that its Board of Directors has authorized a review of strategic alternatives including potential sale, acquisitions, divestitures, or other financial transactions to maximize shareholder value. The review is preliminary with no set timetable or guaranteed outcome. This follows the c…
C4 Therapeutics has entered a new collaboration agreement with Roche focused on developing degrader-antibody conjugates (DACs) for cancer treatment. The deal involves leveraging C4T's TORPEDO platform to design novel degrader payloads and Roche's expertise in antibody-drug conjugation to create and advance DAC candidates. C4T will receive a $20 mil…
Brookfield Wealth Solutions Ltd. announced its year-end 2025 capital position, nearly $20 billion across its regulated insurance subsidiaries and holding companies, a significant increase from $5.7 billion in 2022. The growth was driven by acquisition strategies and retained earnings, supporting its life and annuity and property/casualty insurance …
Toll Brothers Inc., a leading luxury home builder, announces the final opportunity to buy homes in the NorthGrove - Villa Collection community in Magnolia, Texas. The community offers luxury homes with resort-style amenities, set in a master-planned neighborhood close to major highways and schools. Homes are priced from the upper $300,000s with var…
Solaris Resources Inc. has received the Environmental Impact Assessment (EIA) technical approval for its Warintza copper project in Ecuador, marking a significant permitting milestone that de-risks the project. This approval triggers the second tranche of US$50 million under Solaris's US$200 million financing agreement with Royal Gold, strengthenin…
HII welcomed Christopher Miller, the U.S. Navy's portfolio acquisition executive for maritime, at its Ingalls Shipbuilding division. The visit highlighted Ingalls' recent investments exceeding $1 billion in infrastructure and technology to support current and future Navy shipbuilding programs, including destroyers and amphibious assault ships. The …
Weight Watchers announced updates to its Board of Directors committees following the appointment of two new independent directors. The company confirmed that it will not appoint an interim CEO but will continue under its existing Office of the CEO structure during the search for a permanent CEO.
AGA Precision Systems, a subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), announced a second long-term agreement with a globally recognized Tier 1 aerospace and defense company to supply precision CNC-manufactured components. This agreement reinforces AGA's position as a qualified supplier within the U.S. defense supply chain and supports recurring…
InflaRx N.V. announced new in vitro data showing that izicopan, their oral C5a receptor inhibitor, does not cause time-dependent inhibition of CYP3A4 enzyme, indicating a low risk for drug-drug interactions and liver toxicity. These results support izicopan’s differentiated safety and pharmacological profile, reinforcing its potential as a best-in-…
AMN Healthcare Services, Inc. announced its first quarter 2026 earnings conference call to be held on May 7, 2026, along with the release of its financial results and second quarter outlook. The company provides workforce solutions for healthcare and reaches millions of patients through its vast network.
Greenlane Holdings, a Nasdaq-listed digital asset treasury company focused on the Berachain blockchain's native token BERA, updated its treasury holdings, revealing ownership of approximately 77.9 million BERA tokens (32% of circulating supply) and a cash position exceeding $32 million. The company announced a $2 million share repurchase program re…
Toll Brothers, Inc., the leading US luxury home builder, announced a new community, Toll Brothers at Fortune Ridge, coming soon to Southeast, New York. Featuring single-family homes with modern architecture, expansive home sites, and a wide array of amenities, sales are expected to begin in summer 2026. This project highlights the company’s continu…
Kura Oncology announced it will present updated preliminary Phase 1 data from the FIT-001 clinical trial evaluating the combination of darlifarnib and cabozantinib in patients with advanced clear cell renal cell carcinoma previously treated with cabozantinib. Building on earlier encouraging results reported at ESMO 2025, the data support darlifarni…
